The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Happy Belly Food Group Inc
CNSX:HBFG
|
CA |
|
M
|
MindBio Therapeutics Corp
F:WF60
|
CA |
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
KR |
|
E
|
Energy Resources Of Australia Ltd
XMUN:EJ7
|
AU |
|
P
|
Posco M-Tech Co Ltd
KOSDAQ:009520
|
KR |
|
B
|
Banca Generali SpA
SWB:B7A
|
IT |
|
T
|
TSG Star Travel Corp
TPEX:2719
|
TW |
|
P
|
Palomar Holdings Inc
NASDAQ:PLMR
|
US |
|
W
|
Wheels India Ltd
NSE:WHEELS
|
IN |
|
P
|
PDD Holdings Inc
F:9PDA
|
CN |
|
A
|
AXA SA
SWB:AXAA
|
FR |
|
D
|
Descartes Systems Group Inc
NASDAQ:DSGX
|
CA |
|
A
|
AeroVironment Inc
SWB:JPX
|
US |
|
Aneka Tambang Tbk PT
F:AKTA
|
ID |
|
Pantages Capital Acquisition Corp
NASDAQ:PGAC
|
US |
|
F
|
First Community Corp (South Carolina)
NASDAQ:FCCO
|
US |
|
Iondrive Ltd
ASX:ION
|
AU |
|
IRSA Inversiones y Representaciones SA
F:IRY
|
AR |
Happy Belly Food Group Inc (HBFG)’s 12-month stock price forecast through October 2027 has a consensus target of CA$2.52, implying 73% upside. The forecast is based on price targets from 4 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for HBFG is 2.52 CAD with a low forecast of 2.32 CAD and a high forecast of 2.78 CAD.
Over the last 4 years, the compound annual growth rate for Revenue has been 105%. The projected CAGR for the next 3 years is 43%.
Over the last 4 years, the compound annual growth rate for Gross Profit has been 107%. The projected CAGR for the next 2 years is 51%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more